Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Neo Medical (@NEOMEDICAL1) has secured a landmark equity investment of $68 million to accelerate its global growth in spine surgery. This significant funding will enable the company to expand its innovative solutions in the medical field. Additionally, Abrinca Genomics has received a CHF 150,000 boost from Venture Kick, while Zurich-based Fabas has raised CHF 1.3 million. Neopredix has also secured investment from Springhood Ventures.
Proud to announce the most promising Swiss Biotech Startups and Scale-Ups of 2024, picked by a panel of 100 leading investors and industry experts. Read the full article: https://t.co/QrZNT3rgAh Discover the 15 Biotech Startups that impressed the TOP 100 Swiss Startup Award Jury… https://t.co/QwafXBKrL1
Venturelab is happy to invite you to a discovery and networking event, celebrating Swiss and Indian Entrepreneurship, as part of the AIT India program. Listen to the pitches of 10 promising Swiss startups that will participate in the Academia-Industry Training in India, and vote… https://t.co/Q6hLkbZgDI
Today's startup funding news: @NEOMEDICAL1 secures up to $68M, #AbrincaGenomics receives CHF 150'000 boost from @venturekick, @neopredix secures investment from #SpringhoodVentures, and Zurich-based #Fabas raises CHF1.3M https://t.co/dGdnlqfQ54